[en] In the biosocial model of Cloninger, three major personality dimensions, novelty seeking (NS), harm avoidance (HA), and reward dependence (RD) are dependent on central monoaminergic systems, respectively dopaminergic, serotonergic, and noradrenergic. This study investigated the relationships between these major personality dimensions and growth hormone (GH) responses to both apomorphine and clonidine challenge tests in healthy subjects. GH responses to apomorphine were significantly correlated with NS when peak relative values were considered (r=0.47, P=0.03). HA and RD did not show any relationships with the endocrine responses. In contrast, no significant relationship existed between GH responses to clonidine and any of the three temperament dimensions. These results gave another support of the hypothesized link between NS and dopaminergic central neurotransmission. In contrast, the results did not confirm the association between RD and noradrenergic central neurotransmission, probably because RD is poorly validated. This partial confirmation might suggest that the link between personality traits and neurotransmission systems is probably indirect. (C) 2002 Elsevier Science Ltd. All rights reserved.
Research Center/Unit :
Centre de Neurosciences Comportementale et Cognitive
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
Ansseau, M., Von Frenckell, R., Cerfontaine, J-L., Papart, P., Franck, G., Timsit-Berthier, M., Geenen, V., & Legros, J-J. (1988). Blunted response of growth hormone to clonidine and apomorphine in endogenous depression. British Journal of Psychiatry, 153, 65-71.
Benjamin, J., Li, L., Patterson, C., Greenberg, B. D., Murphy, D. L., & Hamer, D. H. (1996). Population and familial association between the D4 dopamine receptor gene and measures of novelty seeking. Nature Genetics, 12, 81-84.
Benjamin, J., Osher, Y., Kotler, M., Gritsenko, I., Nemanov, L., Belmaker, R. H., & Ebstein, R. P. (2000). Association between tridimensional personality questionnaire (TPQ) traits and three functional polymorphisms: dopamine receptor D4 (DRD4), serotonin transporter promoter region (5-HTTLPR) and catechol O-methyltransferase (COMT). Molecular Psychiatry, 5, 96-100.
Bray, G. A. (1978). Definition, measurement, and classification of the syndromes of obesity. International Journal of Obesity, 2, 99-112.
Checkley, S. A., Slade, A. P., & Shur, E. (1981). Growth hormone and other responses to clonidine in patients with endogenous depression. British Journal of Psychiatry, 138, 51-55.
Cloninger, C. R. (1986). A unified biosocial theory of personality and its role in the development of anxiety states. Psychiatry Developments, 3, 167-226.
Cloninger, C. R. (1987). A systematic method for clinical description and classification of personality variants. Archives of General Psychiatry, 44, 573-588.
Cloninger, C. R. (1988). A unified biosocial theory of personality and its role in the development of anxiety states: a reply to commentaries. Psychiatry Developments, 2, 83-120.
Cloninger, C. R., Przybeck, T. R., & Svrakic, D. M. (1991). The tridimensional personality questionnaire: US normative data. Psychological Reports, 69, 1047-1057.
Cloninger, C. R., Przybeck, T. R., Svrakic, D. M., & Wetzel, R. D. (1994). The Temperament and Character Inventory (TCI): a guide to its development and use. St Louis, MO: Center for psychobiology of personality.
Cloninger, C. R., & Svrakic, D. M. (1997). Integrative psychobiological approach to psychiatric assessment and treatment. Psychiatry, 60, 120-141.
Cloninger, C. R., Svrakic, D. M., & Przybeck, T. R. (1993). A psychobiological model of temperament and character. Archives of General Psychiatry, 50, 975-990.
Curtin, F., Walker, J-P., Peyrin, L., Soulier, V., Badan, M., & Schulz, P. (1997). Reward dependence is positively related to urinary monoamines in normal men. Biological Psychiatry, 42, 275-281.
Dinan, T. G., & Barry, S. (1990). Responses of growth hormone to desipramine in endogenous and non-endogenous depression. British Journal of Psychiatry, 156, 680-684.
Ebstein, R. P., Novick, O., Umansky, R., Priel, B., Osher, Y., Blaine, D., Bennett, E. R., Nemanov, L., Katz, M., & Belmaker, R. H. (1996). Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of novelty seeking. Nature Genetics, 12, 78-80.
Eysenck, H. J. (1990). Biological bases of personality. In L. A. Pervin (Ed.), Handbook of personality theory and research (pp. 244-276). New York: Guilford press.
Garvey, M. J., Noyes, R. Jr., Cook, B., & Blum, N. (1996). Preliminary confirmation of proposed link between reward-dependence traits and norepinephrine. Psychiatry Research, 65, 61-64.
Gelder, M. G. (1987). Discussions arising from: Cloninger CR. A unified biosocial theory of personality and its role in the development of anxiety states. Psychiatric Developments, 4, 387-391.
Gerra, G., Zaimovic, A., Timpano, M., Zambelli, U., Delsignore, R., & Brambilla, F. (2000). Neuroendocrine correlates of temperamental traits in human. Psychoneuroendocrinology, 25, 479-496.
Gray, J. A. (1987). Discussions arising from: Cloninger CR. A unified biosocial theory of personality and its role in the development of anxiety states. Psychiatric Developments, 4, 377-385.
Hansenne, M., & Ansseau, M. (1998). Catecholaminergic function and temperament in major depressive disorder: a negative report. Psychoneuroendocrinology, 23, 477-483.
Hansenne, M., & Ansseau, M. (1999). Harm avoidance and serotonin. Biological Psychology, 51, 77-81.
Hansenne, M., Le Bon, O., Gauthier, A., & Ansseau, M. (2001). Belgian normative data of the temperament and character inventory. European Journal of Psychological Assessment, 17, 56-62.
Hansenne, M., Pitchot, W., Gonzalez Moreno, A., Machurot, P-Y., Reggers, J., & Ansseau, M. (1997). The harm avoidance dimension of the tridimensional personality questionnaire and 5-HT1A activity in depression. Biological Psychiatry, 42, 959-961.
Hansenne, M., Pitchot, W., Gonzalez Moreno, A., Von Frenckell, R., & Ansseau, M. (1992). Clonidine test and MMPI scales in major depression. European Psychiatry, 7, 129-133.
Hansenne, M., Reggers, J., Pinto, E., Kjiri, K., Ajamieh, A., & Ansseau, M. (1999). Temperament and character inventory (TCI) and depression. Journal of Psychiatric Research, 33, 31-36.
Hennig, J., Toll, C., Schonlau, P., Rohrmann, S., & Netter, P. (2000). Endocrine responses after d-fenfluramine and ipsapirone challenge: further support for Cloninger's tridimensional model of personality. Neuropsychobiology, 41, 38-47.
Laakmann, G. (1990). Psychopharmacoendocrinology and depression research. Berlin: Springer-Verlag.
Lal, S., De La Vega, S. E., Sourkes, T. L., & Friesen, H. G. (1972). Effect of apomorphine in human growth hormone secretion. Lancet, ii, 661.
Liebowitz, M. R. (1987). Discussions arising from: Cloninger CR. A unified biosocial theory of personality and its role in the development of anxiety states. Psychiatric Development, 4, 385-387.
Limson, R., Goldman, D., Roy, A., Lamparski, D., Ravitz, B., Adino., B., & Linnoila, M. (1991). Personality and cerebrospinal fluid monoamine metabolites in alcoholics and controls. Archives of General Psychiatry, 48, 437-441.
Matussek, N., Ackenheil, M., Hippius, H., Müller, F., Schröder, H. T., Schultes, H., & Walislewski, B. (1980). Effect of clonidine on growth hormone release in psychiatric patients and controls. Psychiatry Research, 2, 25-36.
Meltzer, H. Y., Kolakowska, T., Fang, V. S., Fogg, L., Robertson, A., Lewine, R., Strahilevitz, M., & Busch, D. (1984). Growth hormone response to apomorphine in schizophrenia and the major affective disorders. Archives of General Psychiatry, 41, 512-519.
Mulder, R. T., & Joyce, P. R. (1994). Relationships of the tridimensional personality questionnaire to mood and personality measures for depressed patients. Psychological Reports, 75, 1315-1325.
Pélissolo, A., & Lépine, J.-P. (1997). Traduction française et premireres études de validation du questionnaire de personnalité TCI. Annales Médico-Psychologiques, 155, 497-508.
Pitchot, W., Hansenne, M., Gonzalez Moreno, A., & Ansseau, M. (1992). Suicidal behavior and growth hormone response to apomorphine test. Biological Psychiatry, 31, 1213-1219.
Ruegg, R. G., Gilmore, J., Ekstrom, R. D., Corrigan, M., Knight, B., Tancer, M., Leatherman, M. E., Carson, S. W., & Golden, R. N. (1997). Clomipramine challenge responses covary with Tridimensional Personality Questionnaire scores in healthy subjects. Biological Psychiatry, 42, 1123-1129.
Samochowiec, J., Rybakowski, F., Czerski, P., Zakrzemska, M., Stepienacute, G., Pelka-Wysiecka, J., Horodnicki, J., Rybakowski, J. K., & Hauser, J. (2001). Polymorphisms in the dopamine, serotonin and norepinephrine transporter genes and their relationship to temperament and character inventory in healthy volunteers. Neuropsychobiology, 43, 248-253.
Siever, L. J., Insel, T. R., Jimerson, D. C., Lake, C. R., Uhde, T. W., Aloi, J., & Murphy, D. L. (1983). Growth hormone response to clonidine in obsessive-compulsive patients. British Journal of Psychiatry, 142, 184-187.
Siever, L. J., & Uhde, T. W. (1984). New studies and perspectives on the noradrenergic receptor system in depression: effects of the alpha-2 adrenergic agonist clonidine. Biological Psychiatry, 19, 131-156.
Starke, K. (1981). Presynaptic receptors. Annual Review of Pharmacology and Toxicology, 21, 7-30.
Statsoft Inc. (1993). Statistica (4.5) for Windows. USA: Tulsa.
Suhara, T., Yasuno, F., Sudo, Y., Yamamoto, M., Inoue, M., Okubo, Y., & Suzuki, K. (2001). Dopamine d2 receptors in the insular cortex and the personality trait of novelty seeking. Neuroimage, 13, 891-895.
Svrakic, D. M., Przybeck, T. R., & Cloninger, C. R. (1991). Further contribution to the conceptual validity of the unified biosocial model of personality: US and Yugoslav data. Comprehensive Psychiatry, 32, 195-209.
Tancer, M. E., Ranc, J., & Golden, R. N. (1994). Pharmacological challenge test of the tridimensional personality questionnaire in patients with social phobias and normal volunteers. Anxiety, 1, 224-226.
Tancer, M. E., Stein, M. B., & Uhde, T. W. (1993). Growth hormone response to intravenous clonidine in social phobia: comparison to patients with panic disorder and healthy volunteers. Biological Psychiatry, 34, 591-595.
Thomas, A. E., McKay, D. A., & Cutlip, M. B. (1976). A monograph method for assessing body weight. American Journal of Clinical Nutrition, 29, 302-304.
Tulandi, T., Lal, S., & Guyda, H. (1987). Effect of estrogen on the growth hormone response to the alpha-adrenergic agonist in women with menopausal flushing. Journal of Clinical Endocrinology and Metabolism, 65, 6-10.
Wiesbeck, G. A., Mauerer, C., Thome, J., Jacob, F., & Boening, J. (1995). Neuroendocrine support for a relationship between "novelty seeking" and dopaminergic function in alcohol-dependent men. Psychoneuroendocrinology, 20, 755-761.
Zohar, A. H., Lev-Ari, L., Benjamin, J., Ebstein, R., Lichtenberg, P., & Osher, Y. (2001). The psychometric properties of the Hebrew version of Cloninger's Tridimensional Personality Questionnaire. Personality and Individual Differences, 30, 1297-1309.
Zuckerman, M. (1988). Sensation seeking and behavior disorders. Archives of General Psychiatry, 45, 502-503.
Zuckerman, M., & Cloninger, C. R. (1996). Relationships between Cloninger's, Zuckerman's, and Eysenck's dimensions of personality. Personality and Individual Differences, 21, 283-285.
Similar publications
Sorry the service is unavailable at the moment. Please try again later.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.
